Abstract
Neurally adjusted ventilatory assit (NAVA) is a new mode of mechanical ventilation that delivers ventilatory assist in proportion to neural effort. In contrast to all other modes of ventilation, which adopt conventional pneumatic signals (flow, volume, and airway pressure) to drive and control the ventilator operation, NAVA utilizes the electrical activity of the diaphragm. Ventilating neonatal and pediatric patients in this new mode appears to be safe and well tolerated with improved patient-ventilator synchrony and lower peak airway pressure when compared to pressure support ventilation. Concluding, NAVA improves monitoring of respiratory drive, and delivers synchronized assist in relation to patient effort, and the control of assist is not affected by leaks or auto-PEEP.
Keywords: NAVA, electrical activity of the diaphragm, pressure support ventilation, mechanical ventilation, partial ventilatory assist, pediatric, neonate, diaphragm, patient-ventilator interaction, asynchrony
Current Respiratory Medicine Reviews
Title: Neurally Adjusted Ventilatory Assist - NAVA
Volume: 8 Issue: 1
Author(s): Werther Brunow de Carvalho and Marcelo Cunio Machado Fonseca
Affiliation:
Keywords: NAVA, electrical activity of the diaphragm, pressure support ventilation, mechanical ventilation, partial ventilatory assist, pediatric, neonate, diaphragm, patient-ventilator interaction, asynchrony
Abstract: Neurally adjusted ventilatory assit (NAVA) is a new mode of mechanical ventilation that delivers ventilatory assist in proportion to neural effort. In contrast to all other modes of ventilation, which adopt conventional pneumatic signals (flow, volume, and airway pressure) to drive and control the ventilator operation, NAVA utilizes the electrical activity of the diaphragm. Ventilating neonatal and pediatric patients in this new mode appears to be safe and well tolerated with improved patient-ventilator synchrony and lower peak airway pressure when compared to pressure support ventilation. Concluding, NAVA improves monitoring of respiratory drive, and delivers synchronized assist in relation to patient effort, and the control of assist is not affected by leaks or auto-PEEP.
Export Options
About this article
Cite this article as:
Brunow de Carvalho Werther and Cunio Machado Fonseca Marcelo, Neurally Adjusted Ventilatory Assist - NAVA, Current Respiratory Medicine Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339812798868825
DOI https://dx.doi.org/10.2174/157339812798868825 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fetzima (levomilnacipran), a Drug for Major Depressive Disorder as a Dual Inhibitor for Human Serotonin Transporters and Beta-Site Amyloid Precursor Protein Cleaving Enzyme-1
CNS & Neurological Disorders - Drug Targets Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention
Current Pharmaceutical Design Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?
CNS & Neurological Disorders - Drug Targets Progress of Antiplatelet Pharmacogenomics
Current Drug Targets Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Pre-eclampsia Versus Cardiovascular Disease Versus CRP
Current Hypertension Reviews The Coronary Collateral Circulation in Man
Current Cardiology Reviews Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca<sup>2+</sup> Release Channel: Case Study of Dantrolene
Current Pharmaceutical Design Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
Current Organic Chemistry Stem Cell Patents: An Innovative Approach to Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times
Current Cardiology Reviews Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science The Challenges of Blood Pressure Control in Dialysis Patients
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment
Current Cancer Drug Targets Diabetes in Racial and Ethnic Minorities in the United States: Individualizing Approaches to Diagnosis and Management
Current Diabetes Reviews Myocardial Regeneration: What is the Best Approach?
Current Cardiology Reviews The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews